Services

In order to focus on the most important considerations for SC product development, developers must have a data-driven understanding of contributing factors to SC and IV immunogenicity (features of the immune response, product attributes, etc.) and correlation to safety/adverse events following SC route of delivery. The Immunogenicity sub-team of the Subcutaneous (SC) Drug Development and Delivery Consortium is excited to announce their user group taking place May 14th from 1:30 – 5:00pm ESTÂ...